Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-03

Clinical Trial Update: Study to Evaluate the Safety, Tolerability and Efficacy of BF-200 ALA (Ameluz®) in the Field-directed Treatment of Actinic Keratosis (AK) on the Extremities and Neck/Trunk With Photodynamic Therapy (PDT) Using a RhodoLED Lamp [Phase 3]

View source ↗

Summary

A Phase 3 study to evaluate the safety, tolerability, and efficacy of Ameluz (BF-200 ALA) for field-directed photodynamic therapy of actinic keratosis on the ex…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AMELUZ (AMINOLEVULINIC ACID HYDROCHLORIDE)

Snippet

Sponsor: Biofrontera Inc. | Conditions: Actinic Keratoses | Phase 3 | Status: ACTIVE_NOT_RECRUITING